OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost-Effectiveness of Biosimilars vs Leflunomide in Patients With Rheumatoid Arthritis
Kuan Peng, Shirley Chiu Wai Chan, Yang Wang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2418800-e2418800
Open Access | Times Cited: 7
Kuan Peng, Shirley Chiu Wai Chan, Yang Wang, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2418800-e2418800
Open Access | Times Cited: 7
Showing 7 citing articles:
A Narrative Review of Adalimumab for the Treatment of Cardiac Sarcoidosis
Arnaud Dominati, Christian Ascoli, Israel Rubinstein, et al.
Heart Rhythm O2 (2025)
Open Access
Arnaud Dominati, Christian Ascoli, Israel Rubinstein, et al.
Heart Rhythm O2 (2025)
Open Access
B/ts DMARDs Utilization in the Management of Rheumatoid Arthritis: A Descriptive Study of a 12‐Year Retrospective Cohort in Hong Kong
Kuan Peng, Elkie Chan Yu Kiu, Victoria Anna Yeo, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
Kuan Peng, Elkie Chan Yu Kiu, Victoria Anna Yeo, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 2
Closed Access
[Artículo traducido] Análisis costes-efectividad del tocilizumab biosimilar subcutáneo en pacientes con artritis reumatoide en España
Fernando Perez‐Ruiz, Carlos Crespo-Diz, Joan Antoni Schoenenberger-Arnaiz, et al.
Farmacia Hospitalaria (2025)
Open Access
Fernando Perez‐Ruiz, Carlos Crespo-Diz, Joan Antoni Schoenenberger-Arnaiz, et al.
Farmacia Hospitalaria (2025)
Open Access
Physicians’ and patients’ perception of biosimilars and factors affecting biosimilar prescribing in selected Asian Countries: a survey study
Supat Thongpooswan, Anupam Das, Pravin Patil, et al.
Expert Opinion on Biological Therapy (2024), pp. 1-12
Open Access | Times Cited: 2
Supat Thongpooswan, Anupam Das, Pravin Patil, et al.
Expert Opinion on Biological Therapy (2024), pp. 1-12
Open Access | Times Cited: 2
Explainable biology for improved therapies in precision medicine: AI is not enough
Igor Jurišica
Best Practice & Research Clinical Rheumatology (2024), pp. 102006-102006
Closed Access | Times Cited: 1
Igor Jurišica
Best Practice & Research Clinical Rheumatology (2024), pp. 102006-102006
Closed Access | Times Cited: 1
Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain
Fernando Perez‐Ruiz, Carlos Crespo-Diz, Joan Antoni Schoenenberger-Arnaiz, et al.
Farmacia Hospitalaria (2024)
Open Access
Fernando Perez‐Ruiz, Carlos Crespo-Diz, Joan Antoni Schoenenberger-Arnaiz, et al.
Farmacia Hospitalaria (2024)
Open Access
Fostering healthcare system sustainability through efficient practices: Can adopting biosimilars ease the financial burden of rheumatoid arthritis?
Christos Ntais, Nick Kontodimopoulos, John Fanourgiakis, et al.
F1000Research (2024) Vol. 13, pp. 1128-1128
Open Access
Christos Ntais, Nick Kontodimopoulos, John Fanourgiakis, et al.
F1000Research (2024) Vol. 13, pp. 1128-1128
Open Access
